Navigation Links
Yongye Biotechnology to Present at Roth Conference
Date:2/9/2009

BEIJING, Feb. 9 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals, located in the People's Republic of China, today announced that the Company's management will present at the upcoming Roth 21st Annual OC Growth Stock Conference in Dana Point, California.

The date, time, presenters, and location of Yongye Biotechnology International, Inc.'s presentation at the conference are as follows:

    Date:           Wednesday, February 18, 2009
    Time:           11:30 a.m. Pacific Time
    Presenters:     Mr. Zishen Wu, Chairman and CEO;
                    Mr. Larry Gilmore, Vice President of Corporate Strategy
    Venue:          Track 5
                    The Ritz Carlton Laguna Niguel
                    One Ritz-Carlton Drive
                    Dana Point, California 92629

The ROTH 21st Annual OC Growth Stock Conference will feature presentations from over 200 growth companies. This event is designed to provide investors with a unique opportunity to gain insight into leading companies across all sectors. Additionally, there will be a special track dedicated to companies based in China. Presentations will provide a brief overview of the company's operations, and speakers will spend the majority of their time discussing topics that will highlight the value and investment opportunity their company represents.

The Company will be available to meet with analysts and investors during the conference. Interested parties and investors may find more information about the conference by contacting conference@roth.com or calling (800) 933-6830.

About Yongye Biotechnology Internationa
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Yongye Biotechnology Announces Record Third Quarter Results
2. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
3. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
4. Yongye Biotechnology International Raises $9.4 Million in Private Placement
5. Yongye Biotechnology International Announces Second Quarter Results
6. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
7. Yongye Biotechnology International Retains CCG Investor Relations
8. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
9. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
10. MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference
11. Energy, Biotechnology and Agribusiness Veterans Form SG Biofuels to Develop Jatropha as Low-Cost, Sustainable Oil

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...alif., Nov. 30 BioMarin ...ay that the Food and Drug Administration (FDA) has...ridine (3,4-DAP), amifampridine phosphate, for the...Syndrome (LEMS). 3,4-DAP has previously received ...ber 2009, the Committee for Medicinal Products for...
(Date:11/30/2009)... and COPENHAGEN, Nov. 30 Exiqon A/...hat the Harvard Medical School ICCB-Longwood Scree...croRNA Screening Center of Excellence. ICCB-L sup... associated hospitals and institutions, for high-t...raries. ,, MicroRNAs are a novel class of small...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNew...publisher of scientific, medical and technical pro...nch of Embase, its comprehensive biomedical,databa...m more than 7,000,active, peer reviewed journals. ...e advancement of new biomedical,and pharmaceutical...
(Date:11/27/2009)...RHAM, N.C., Nov. 27 Cromoz Inc., l...ter-soluble carbon nanotube-based cancer drug deli... carbon nanotubes, which have functional groups on... drugs, was developed in partnership with the Indi...n nanotubes serves as a drug delivery vehicle with...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...emand for Food, Feed, Fuel, Materials, DES MOINES...CEO Charles O. Holliday, Jr., Executive Vice Presi..., and Group Vice President -- DuPont,Agriculture &... on DuPont,businesses serving the agriculture and ...ng income and demand for biofuels is,driving incre...
...harmaceuticals, Inc. (NYSE: BRL ) today confirmed... initiated a challenge of the patent listed by,War...Chilcott,s Femcon(R),FE (norethindrone and ethinyl...ny believes that it is the first to file an Abbrev...agraph IV certification for Femcon FE. Barr filed...
.... (Other,OTC: BMXSF), is pleased to announce it ha...logies Ltd., for the provision of the design, manu...ery. Pursuant to the engagement,letter, Alcofuel T...onditions of the engagement letter, to design and ...apable of producing 30,000 litres of ethanol,per d...
Other Biology Technology:DuPont Leaders Brief Investors on Agriculture Businesses 2DuPont Leaders Brief Investors on Agriculture Businesses 3Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product 2Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product 3BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery 2
(Date:11/30/2009)...s a colorless and odorless radioactive gas that is...um is a product of uranium decay and is found in t... and groundwater as well as building materials, pl...entration is expressed as the amount of radiation ...cts in a liter of air; thus the units are picocuri...
(Date:11/26/2009)...r their impressive antlers, red deer have been cau...deer,s antlers are much more than decorative. They... duelling. John Currey, from The University of Yor...ties of bone for over half a century and has becom...r through a long-standing collaboration with Tomas...
(Date:11/26/2009)...carried out in eight European countries has shown ... disease pandemic could have a significant role in...g in the open access journal BMC Infectious Disea...l days and weekends/holidays, finding that they we...rom Hasselt and Antwerp University, Belgium, led a...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2People Across the Country are Making The Switch 21 53059 1People Across the Country are Making The Switch 21 53059 2Smart for Life 28TM 29 and THINADVENTURE 28TM 29 Sponsor Brandon Flowers Youth Sports Camp 53056 1Smart for Life 28TM 29 and THINADVENTURE 28TM 29 Sponsor Brandon Flowers Youth Sports Camp 53056 2Smart for Life 28TM 29 and THINADVENTURE 28TM 29 Sponsor Brandon Flowers Youth Sports Camp 53056 3ImmuneRegen BioSciences Confirms Homsperas Therapeutic Anti Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration 13250 1ImmuneRegen BioSciences Confirms Homsperas Therapeutic Anti Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration 13250 2ImmuneRegen BioSciences Confirms Homsperas Therapeutic Anti Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration 13250 3
...ed by Rutgers, Samuel Gunderson has developed a no...improvements over existing RNAi approaches. This m...lass of drugs to treat a wide array of diseases. C...m took to specifically target RNA biosynthesis. ,... Nature Biotechnology , published online in the F...
...vance online publication of the journal Nature , ...t viral proteins perform to create the infectious ...ease, say researchers. While the virus they studie... such as herpes and HIV are also known to assemble...its final assault-proof, infectious form. , "The ...
...nerate Energy from Waste Biomass , , ATLANTA, Feb...versified renewable energy company, Global Energy ...ounced the execution of a definitive agreement to ...ndscape materials processor, WoodTech, LLC, and af...expected to occur in mid-February, 2009. , , "We ...
Other Biology News:A new gene silencing platform -- silence is golden 2Scripps scientists create first crystal structure of an intermediate particle in virus assembly 2Scripps scientists create first crystal structure of an intermediate particle in virus assembly 3Global Energy Systems to Acquire WoodTech, LLC, and Affiliated Entities 2Global Energy Systems to Acquire WoodTech, LLC, and Affiliated Entities 3
Calcium Flux Antagonist Chip, 4-Sipper (coated) from Caliper Life Sciences
SYBR Gold nucleic acid gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
Experion RNA StdSens Chips, 10 from Bio-Rad
Experion RNA HighSens Chips, 10 from Bio-Rad
Biology Products: